Daniel Przybysz


Dr. Daniel Przybysz is a Brazilian Radiation-Oncologist. His practice is mainly focused on lung cancer treatment and high technology approaches toward better patient care
Przybysz has a medical degree from the Federal University of Parana, Brazil jointly with Harvard Medical School. He graduated in 2013 with high-honors after doing his internships in Oncology-related rotations.
After spending some time at the Massachusetts General Hospital in Boston and at the University of Texas University of Texas [MD Anderson Cancer Center|MD Anderson Cancer Center], Przybysz began a Radiation-Oncology program at the Brazilian National Cancer Institute. He graduated residency and was invited to start a position as Visitor Researcher in Radiation-Oncology at the Washington [University School of Medicine].
Przybysz also works as an Oncology Reviewer for UpToDate and as an author, editor and reviewer for lung-related articles at the International Journal of Radiation Oncology, Biology and Physics, contributing on high-level reviews for medical content.

Publications

Przybysz's interest in clinical cancer research and outcomes has culminated in several publications, some of listed below:
  • Magnetic Resonance Image-Guided Radiation Therapy for the Treatment of Prostate Cancer: Initial Patient Selection and Clinical Experience - Journal of Urology 2017
  • Lung SBRT using MRI-guided radiation therapy: possible GTV changes and benefits of adaptive therapy In Silico Trial of MR-Guided Mid-Treatment Adaptive Planning for Hypofractionated Stereotactic Radiotherapy in Centrally Located Thoracic Tumors - IJROBP 2016
  • Lung SBRT using MRI-guided radiation therapy: possible GTV changes and benefits of adaptive therapy - SBRT 2016
  • A comparison between VMAT, IMRT and GAP techniques on the Medulloblastoma approach: different technologies aiming better patient care - Radiology 2015
  • Potential benefits of Neoadjuvant Radiation Therapy On Overall Survival in Advanced Breast Cancer Patients - Radiology 2016
Nevertheless, Przybysz is now developing projects using high-technology treatment planning towards better patient care. At present, he is engaged in several studies regarding lung cancer, CNS malignancies and prostate cancer.
He has been recognized and awarded as a Leading Physician of The World by the International Association of Healthcare Providers in 2017.